Lyka Labs - Quaterly Results

09 Nov 2022 Evaluate
The sales slipped to Rs. 221.27 millions, down -65.97% for the September 2022 quarter as against Rs. 650.18 millions during the year-ago period.The Net Loss for the quarter ended September 2022 is Rs. -3.96 millions as compared to Net Profit of Rs. 298.12 millions of corresponding quarter ended September 2021The company reported a degrowth in operating Profit to 57.70 millions from 450.63 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 221.27 650.18 -65.97 440.05 1084.84 -59.44 1643.49 622.63 163.96
Other Income 10.39 8.56 21.38 17.23 13.87 24.22 27.20 22.10 23.08
PBIDT 57.70 450.63 -87.20 123.74 754.00 -83.59 1002.19 166.35 502.46
Interest 29.14 55.27 -47.28 57.15 124.17 -53.97 199.21 255.53 -22.04
PBDT 27.19 374.93 -92.75 65.21 609.40 -89.30 756.30 -103.47 -830.94
Depreciation 34.55 20.88 65.47 68.69 41.40 65.92 153.89 80.50 91.17
PBT -7.36 354.05 -102.08 -3.48 568.00 -100.61 602.41 -183.97 -427.45
TAX -3.40 55.93 -106.08 -2.79 73.43 -103.80 203.38 -39.36 -616.72
Deferred Tax -3.40 55.93 -106.08 -2.79 73.43 -103.80 203.38 -39.36 -616.72
PAT -3.96 298.12 -101.33 -0.69 494.57 -100.14 399.03 -144.61 -375.94
Equity 286.90 286.90 0.00 286.90 286.90 0.00 286.90 286.90 0.00
PBIDTM(%) 26.08 69.31 -62.38 28.12 69.50 -59.54 60.98 26.72 128.24

Lyka Labs Share Price

78.32 -2.72 (-3.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×